Citation: | HU Yong, MOU Hai-jun, CHEN Ke. Clinical Effect Observation of Jianpishugan and Huoxuehuatan Formula on Liver Depression and Spleen Deficiency Induced Non-Alcoholic Steatohepatitis[J]. Journal of Nanjing University of traditional Chinese Medicine, 2017, 33(4): 359-362. |
[1] |
王唯坚, 胡唆. 155例非酒精性脂肪肝患者的中医证候学研究[J]. 首都医科大学学报, 2014, 35(1): 129-131.
|
[2] |
WANG WJ, HU S. The traditional Chinese medical syndrome study on 155 patients with non-alcoholic fatty liver disease[J]. J Cap Univ Med Sci, 2014, 35(1): 129-131.
|
[3] |
陈祈玲.台湾非酒精性脂肪肝病之流行病学[J]. 临床肝胆病杂志, 2010, 26(2):144-146.
|
[4] |
CHEN QL. Epidemiology of nonalcoholic fatty liver disease in Taiwan[J]. J Clin Hepatol, 2010, 26(2): 144-146.
|
[5] |
任路平,宋光耀.非酒精性脂肪肝疾病发生机制研究新进展[J].中国老年学杂志,2012, 32(3):664-666.
|
[6] |
REN LP, SONG GY. Research progress of occurrence mechanism of non-alcoholic fatty liver disease[J]. Chin J Gerontol, 2012, 32(3): 664-666.
|
[7] |
中华医学会肝病学分会脂肪肝和酒精性肝病专业委员会. 非酒精性脂肪性肝病诊疗指南[S]. 药品评价,2007,4(2): 77-79.
|
[8] |
Chinese Society of Hepatology, Fatty Liver and Alcoholic Liver Disease, Specialized Committee. Guidelines for Diagnosis and Treatment of Nonalcoholic Fatty Liver Diseases[S]. Drug Eval, 2007, 4(2): 77-79.
|
[9] |
中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:86-89.
|
[10] |
Guideline for Clinical Trials of New Patent Chinese Medicines[M]. Beijing: China medical science and technology press, 2002: 86-89.
|
[11] |
冯高飞, 陈若. 疏肝健脾方治疗肝郁脾虚型非酒精性脂肪性肝炎40例[J]. 中医研究, 2015, 28(10):5-6.
|
[12] |
FENG GF, CHEN R. Shugan Jianpi Formula in the treatment 40 cases of liver depression and spleen deficiency induced non-alcoholic steatohepatitis[J]. Res Chin Med, 2015, 28(10): 56.
|
[13] |
陈峰.逍遥散加减治疗肝郁脾虚型非酒精性脂肪性肝炎 33 例[J]. 福建中医药, 2010, 41(3): 43-44.
|
[14] |
CHEN F. Modified Xiaoyao Powder in the treatment of 33 cases of liver depression and spleen deficiency induced non-alcoholic steatohepatitis[J]. Fujian Chin Med, 2010, 41(3): 43-44.
|
[15] |
王雁翔,王灵台, 高月求,等.脂肪肝中医证型流行病学调查及其中医病因病机初探[J]. 中国中西医结合杂志,2005, 25(2): 129.
|
[16] |
WANG YX, WANG LT, GAO YQ, et al. Epidemic survey on TCM syndrome typing and preliminary discussion on TCM etiology and pathogenesis of fatty liver[J]. Chin J Integr Trad West Med, 2005, 25(2): 129.
|